Enza Biotech AB, a research enterprise established as a spin-out company from Lund University, has been acquired by Croda International PLC (’Croda’). Moll Wendén has advised the sellers in the acquisition.
Enza Biotech was founded in 2012 by researchers at Lund University with the aim to develop the next generation of renewable surfactants using carbohydrate-based chemistry. Croda makes, creates and sells innovative and sustainable speciality chemicals.
Maria Andersson, Chief Executive Office and co-founder of Enza Biotech said:” Croda is the perfect fit for our technology due to their commitment to investing in innovative and sustainable solutions.”
Moll Wendén has advised the sellers, Enza Biotech, in the acquisition. Martin Morén Jönsson, partner at Moll Wendén lead the team also consisting of Henric Stråth and Jenny Forsberg.
Martin Morén Jönsson, partner at Moll Wendén, phone: +46703-26 65 04, e-mail: email@example.com